Abacavir Sulfate (188062-50-2): A Thorough Overview

Abacavir Sulfate (CAS number 188062-50-2) is a potent antiviral mainly utilized in the treatment of Human Immunodeficiency Virus (HIV) and associated opportunistic illnesses . It functions as a reverse transcriptase blocker , interfering with the HIV's reproduction process . Administered often in combination other AIDS compounds, abacavir has a cri

read more

Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, is a potent HIV medication. It blocks the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme is essential in the HIV life cycle, facilitating the virus to insert its genetic material into the host's DNA. Abacavi

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor utilized in the therapy of human immunodeficiency virus disease. Its pharmacological properties involve the competitive inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a pro-drug that transits transformation to its active form,

read more

Premier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for enterprises of all sizes. A leading global API manufacturer and supplier provides a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a unwavering commitment to quality, innovation, and

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor administered in the treatment of human immunodeficiency virus syndrome. Its mechanistic properties rely on the competitive inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a metabolite that experiences conversion to its active f

read more